Colombo Stock Exchange closed lower: ASPI fell 0.28% (down 56.48 pts) to 19,927.30 and the S&P SL20 fell 0.43% to 5,656.91. Market turnover was LKR 1.5 billion; top gainers included Distilleries, PGP Glass, Singer and Asiri, while Carson Cumberbatch, Bukit Darah, JKH, Hayleys and Commercial Bank led decliners.
Dialog Axiata reduced its combined stake in Digital Health from 64.66% to 44.66%, selling 16.65% (3,747,132 shares) to Sunshine Healthcare for LKR 312.17m and 3.35% (752,868 shares) to Nawaloka for LKR 62.72m; Digital Health will be reclassified from a subsidiary to an associate. Sunshine now holds 21.92%; Nawaloka 12.12%; Asiri 13.33%.
Sunshine Holdings' unit Sunshine Healthcare bought a 21.92% stake in Digital Health (Doc990) for LKR 410.83 million via two share purchase agreements on Oct 16, acquiring 16.65% from Dialog Axiata's subsidiary and 5.26% from Ceylon Hospitals.
Dialog Axiata sold part of its stake in Digital Health (Doc990), reducing the Dialog Group's holding to 44.66% and causing Digital Health to cease being a Group subsidiary. Sunshine Healthcare paid to become a c.21.92% holder (total outlay Rs.410.8m) while Nawaloka raised its stake to 12.12% and Durdans exited; price was Rs.83.31/share valuing Digital Health at Rs.1.87bn.
Colombo bourse opened flat with the ASPI down 0.06% at 20,173.56 and market turnover Rs 232.69m (banks led turnover Rs 108.38m). Sunshine Holdings' unit bought ~21.92% of Digital Health for Rs 410.83m; Union Chemicals declared a Rs48 interim dividend (record date Oct 28, pay Nov 13, 2026).
Colombo bourse closed the week up 3.45% as the ASPI rose 0.54% yesterday to 23,654.30, with the market gaining about Rs. 264.8 billion in value for the week and daily turnover over Rs. 8.5 billion; top contributors included JKH, COMB, VONE, CARS and NTB.
Ceylon Hospitals (Durdans) will seek shareholder approval to subdivide voting shares from 31,762,723 to 127,050,892 and non-voting shares from 10,133,765 to 40,535,060 (1-for-4); stated capital will remain at 1,778,802,331.50 rupees and the plan is pending regulatory approval.
Ceylon Hospitals (Durdens) will propose a 4-for-1 subdivision of both ordinary voting and non-voting shares, subject to regulatory and shareholder approvals. Voting shares would rise to 127,050,892 and non-voting to 40,535,060, with stated capital unchanged at Rs. 1,778,802,331.50.
Healthcare & Pharma
Page 1
That is the last 30 days. Sign in to read back 24 months.